This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Kuni Fushikida: Innovator in Delivery Proteins
Introduction
Kuni Fushikida is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of delivery proteins that enhance the transfer of substances into cells.
Latest Patents
Fushikida holds a patent for a "Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell." This innovative patent describes delivery proteins designed to transfer proteins, antibodies, or foreign substances into cells without compromising their function or structure. The invention outlines methods for efficiently transferring foreign substances into cells using the delivery protein in conjunction with envelope viruses or inactivated envelope viruses. The discovery that a protein containing a polypeptide with an affinity for envelope virus constituents can facilitate the efficient enclosure of foreign substances is a key aspect of this patent. This advancement allows for the effective transfer of substances into cells while preserving their physiological functions.
Career Highlights
Kuni Fushikida is associated with Ishihara Sangyo Kaisha, Ltd., where he continues to work on innovative solutions in biotechnology. His research and development efforts have led to advancements that could significantly impact medical and therapeutic applications.
Collaborations
Fushikida collaborates with Yoshitaka Kondo, a talented woman in the field, contributing to the advancement of their shared research goals.
Conclusion
Kuni Fushikida's work in developing delivery proteins represents a significant advancement in biotechnology. His innovative approach to transferring substances into cells has the potential to enhance various medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile